Comparison between Paytm IPO and Windlas Biotech IPO.
Paytm IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Windlas Biotech IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Paytm IPO is up to ₹18,300.00 Cr whereas the issue size of the Windlas Biotech IPO is up to ₹401.54 Cr. The final issue price of Paytm IPO is ₹2,150.00 per share and of Windlas Biotech IPO is ₹460.00 per share.
| Paytm IPO | Windlas Biotech IPO | |
|---|---|---|
| Face Value | ₹1 per share | ₹5 per share |
| Issue Price (Lower) | ₹2,080.00 per share | ₹448.00 per share |
| Issue Price (Upper) | ₹2,150.00 per share | ₹460.00 per share |
| Issue Price (Final) | ₹2,150.00 per share | ₹460.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 6 shares | 30 shares |
| Fresh Issue Size | 3,86,04,651 shares | 35,86,956 shares |
| Fresh Issue Size (Amount) | up to ₹8,300.00 Cr | up to ₹165.00 Cr |
| OFS Issue Size | 4,65,11,627 shares | 51,42,067 shares |
| OFS Issue Size (Amount) | up to ₹10,000.00 Cr | up to ₹236.54 Cr |
| Issue Size Total | 8,51,16,278 shares | 87,29,023 shares |
| Issue Size Total (Amount) | up to ₹18,300.00 Cr | up to ₹401.54 Cr |
Paytm IPO opens on Nov 08, 2021, while Windlas Biotech IPO opens on Aug 04, 2021. The closing date of Paytm IPO and Windlas Biotech IPO is Nov 10, 2021, and Aug 06, 2021, respectively.
| Paytm IPO | Windlas Biotech IPO | |
|---|---|---|
| Anchor Bid Date | Nov 03, 2021 | Aug 03, 2021 |
| Issue Open | Nov 08, 2021 | Aug 04, 2021 |
| Issue Close | Nov 10, 2021 | Aug 06, 2021 |
| Basis Of Allotment (Tentative) | Nov 15, 2021 | Aug 11, 2021 |
| Initiation of Refunds (Tentative) | Nov 16, 2021 | Aug 12, 2021 |
| Credit of Share (Tentative) | Nov 17, 2021 | Aug 13, 2021 |
| Listing date (Tentative) | Nov 18, 2021 | Aug 16, 2021 |
| Anchor Lockin End date 1 | Dec 15, 2021 | Sep 10, 2021 |
| Anchor Lockin End date 2 | Feb 13, 2022 | Nov 09, 2021 |
Paytm IPO P/E ratio is , as compared to Windlas Biotech IPO P/E ratio of .
| Paytm IPO | Windlas Biotech IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 78 | |||||
| Promoter Shareholding (Post-Issue) | 65.16 | |||||
| P/E Ratio | ||||||
| Market Cap | ₹139378.84 Cr. | ₹1002.54 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Paytm IPO Retail Individual Investors (RII) are offered 85,11,627 shares while in Windlas Biotech IPO retail investors are offered 85,11,627 shares. Qualified Institutional Buyers (QIB) are offered 2,55,34,884 shares in Paytm IPO and 17,45,804 shares in Windlas Biotech IPO.
| Paytm IPO | Windlas Biotech IPO | |
|---|---|---|
| Anchor Investor Reservation | 3,83,02,326 shares | 26,18,706 shares |
| Market Maker Reservation | ||
| QIB | 2,55,34,884 shares | 17,45,804 shares |
| NII | 1,27,67,441 shares | 13,09,354 shares |
| RII | 85,11,627 shares | 30,55,159 shares |
| Employee | ||
| Others | ||
| Total | 8,51,16,278 shares | 87,29,023 shares |
Paytm IPO subscribed 1.89x in total, whereas Windlas Biotech IPO subscribed 22.44x.
| Paytm IPO | Windlas Biotech IPO | |
|---|---|---|
| QIB (times) | 2.79x | 24.40x |
| NII (times) | 0.24x | 15.73x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1.66x | 24.22x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.89x | 22.44x |
